Does Dr. BAHAR BASSIRI GHARB have financial conflicts of interest?

Dr. BAHAR BASSIRI GHARB (M.D., PHD) has received a total of $2,752 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,752 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. BAHAR BASSIRI GHARB?

According to CMS Open Payments data, Dr. BAHAR BASSIRI GHARB received funding from KLS-MARTIN L.P ($1,187), INTEGRA LIFESCIENCES CORPORATION ($385), and ABBVIE ($298).

Does Dr. BAHAR BASSIRI GHARB receive research grants or speaking fees?

Dr. BAHAR BASSIRI GHARB has received $2,752 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. BAHAR BASSIRI GHARB

M.D., PHDReal-Time Hydrated

Specialty: Plastic Surgery

Practice Location: CLEVELAND, OH 44195

NPI Number: 1053609453

LIFETIME INDUSTRY VALUE

$2,752

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BASSIRI GHARB is a verified Plastic Surgery practitioner based in CLEVELAND, OH.

Between 2021 and 2025, Dr. BASSIRI GHARB had an overall industry promotional and research financial footprint of $2,752 as recorded in the federal CMS Open Payments database.

$2,752 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BASSIRI GHARB's primary funding source is KLS-MARTIN L.P, which accounts for $1,187 (representing 43.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

KLS-MARTIN L.P

Rank 1

$1,187

43.1%

INTEGRA LIFESCIENCES CORPORATION

Rank 2

$385

14%

ABBVIE

Rank 3

$298

10.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.